Literature DB >> 21475771

Phospholipid binding lowers immunogenicity of human recombinant factor VIII in von Willebrand factor knockout mice.

D S Pisal, S V Balu-Iyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21475771      PMCID： PMC3970404          DOI： 10.1160/TH10-09-0628

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  21 in total

1.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

2.  Lower inhibitor development in hemophilia A mice following administration of recombinant factor VIII-O-phospho-L-serine complex.

Authors:  Vivek S Purohit; Karthik Ramani; Rita Sarkar; Haig H Kazazian; Sathyamangalam V Balasubramanian
Journal:  J Biol Chem       Date:  2005-02-23       Impact factor: 5.157

Review 3.  B-cell and T-cell epitopes in anti-factor VIII immune responses.

Authors:  Kathleen P Pratt; Arthur R Thompson
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

4.  Comparison of the immunogenicity of different therapeutic preparations of human factor VIII in the murine model of hemophilia A.

Authors:  Sandrine Delignat; Suryasarathi Dasgupta; Sébastien André; Ana-Maria Navarrete; Srinivas V Kaveri; Jagadeesh Bayry; Marie-Hélène André; Sami Chtourou; Zéra Tellier; Sébastien Lacroix-Desmazes
Journal:  Haematologica       Date:  2007-10       Impact factor: 9.941

Review 5.  Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells.

Authors:  S V Kaveri; S Dasgupta; S Andre; A-M Navarrete; Y Repessé; B Wootla; S Lacroix-Desmazes
Journal:  Haemophilia       Date:  2007-12       Impact factor: 4.287

Review 6.  The role of VWF in the immunogenicity of FVIII.

Authors:  Sébastien Lacroix-Desmazes; Yohann Repessé; Srinivas V Kaveri; Suryasarathi Dasgupta
Journal:  Thromb Res       Date:  2008       Impact factor: 3.944

7.  Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A.

Authors:  Karthik Ramani; Razvan D Miclea; Vivek S Purohit; Donald E Mager; Robert M Straubinger; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2008-04       Impact factor: 3.534

8.  A role for thrombin in the initiation of the immune response to therapeutic factor VIII.

Authors:  Jonathan Skupsky; Ai-Hong Zhang; Yan Su; David W Scott
Journal:  Blood       Date:  2009-09-30       Impact factor: 22.113

9.  Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice.

Authors:  Mohammad Qadura; Braden Waters; Erin Burnett; Rouzbeh Chegeni; Scott Bradshaw; Christine Hough; Maha Othman; David Lillicrap
Journal:  Blood       Date:  2009-05-01       Impact factor: 22.113

10.  Antihuman factor VIII C2 domain antibodies in hemophilia A mice recognize a functionally complex continuous spectrum of epitopes dominated by inhibitors of factor VIII activation.

Authors:  Shannon L Meeks; John F Healey; Ernest T Parker; Rachel T Barrow; Pete Lollar
Journal:  Blood       Date:  2007-09-11       Impact factor: 22.113
View more
  1 in total

1.  Native-like aggregates of factor VIII are immunogenic in von Willebrand factor deficient and hemophilia a mice.

Authors:  Dipak S Pisal; Matthew P Kosloski; C Russell Middaugh; Richard B Bankert; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2012-03-02       Impact factor: 3.534
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.